| abstract |
The present invention is a chemical formula that expresses excellent human SGLT activity inhibitory activity and is useful as a prophylactic or therapeutic agent for diseases caused by hyperglycemia such as diabetes, postprandial hyperglycemia, abnormal glucose tolerance, diabetic complications, obesity, etc.n n n n n n n n (R 1 is H, halogen, OH, etc .; R 2 is H, halogen or alkyl; R 3 and R 4 are H, OH, halogen, etc .; Q is alkylene, etc .; Ring A is aryl or heteroaryl; G isn n n n n n n n orn n n n n n n n It is to provide a condensed heterocyclic derivative or a pharmacologically acceptable salt thereof, or a prodrug thereof, a pharmaceutical composition containing the same, and a pharmaceutical use thereof.n n n Human SGLT inhibitory activity, diabetes, postprandial hyperglycemia, impaired glucose tolerance, diabetic complications, obesity, hyperglycemia, condensed heterocyclic derivatives, SGLT. |